speb/financial-data huggingface dataset:
INVX income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 56868000.00
INVX income_statement (annual, 2024-12-31) — Normalized Income: 91524948.00
INVX income_statement (quarterly, 2024-12-31) — Normalized Income: 43233520.00
INVX cash_flow (annual, 2024-12-31) — Operating Cash Flow: 93439000.00
INVX cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 36345000.00
INVX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -8481000.00
INVX cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -8096000.00
INVX income_statement (annual, 2024-12-31) — Operating Income: 85243000.00
INVX income_statement (quarterly, 2024-12-31) — Operating Income: 34553000.00
INVX income_statement (annual, 2024-12-31) — Operating Revenue: 660803000.00
INVX income_statement (quarterly, 2024-12-31) — Operating Revenue: 250687000.00
INVX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 69178262.00
INVX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 69178262.00
INVX balance_sheet (annual, 2024-12-31) — Other Current Assets: 5132000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 5132000.00
INVX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 5000000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 5000000.00
INVX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2387000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 2387000.00
INVX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -8863000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -8863000.00
INVX income_statement (annual, 2024-12-31) — Other Income Expense: 59999000.00
INVX income_statement (quarterly, 2024-12-31) — Other Income Expense: -6765000.00
INVX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 108363000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 108363000.00
INVX cash_flow (annual, 2024-12-31) — Other Non Cash Items: -85403000.00
INVX cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 7240000.00
INVX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 7354000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 7354000.00
INVX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 5991000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 5991000.00
INVX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -298000.00
INVX income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -700000.00
INVX balance_sheet (annual, 2024-12-31) — Other Properties: 75562000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Properties: 75562000.00
INVX balance_sheet (annual, 2024-12-31) — Other Receivables: 33337000.00
INVX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 33337000.00
INVX balance_sheet (annual, 2024-12-31) — Payables: 78934000.00
INVX balance_sheet (quarterly, 2024-12-31) — Payables: 78934000.00
INVX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 125794000.00
INVX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 125794000.00
INVX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
INVX balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
INVX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 20716000.00
INVX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 20716000.00
INVX income_statement (annual, 2024-12-31) — Pretax Income: 142812000.00
INVX income_statement (quarterly, 2024-12-31) — Pretax Income: 27413000.00
INVX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 3326000.00
INVX cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
INVX balance_sheet (annual, 2024-12-31) — Properties: 0.00
INVX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
INVX cash_flow (annual, 2024-12-31) — Purchase Of Business: -65521000.00
INVX cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -65521000.00
INVX balance_sheet (annual, 2024-12-31) — Raw Materials: 53586000.00
INVX balance_sheet (quarterly, 2024-12-31) — Raw Materials: 53586000.00
INVX balance_sheet (annual, 2024-12-31) — Receivables: 266343000.00
INVX balance_sheet (quarterly, 2024-12-31) — Receivables: 266343000.00
INVX balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -63875000.00
INVX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 419855000.00
INVX income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 163264000.00
INVX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 39524000.00
INVX income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 14592000.00
INVX income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 13691000.00
INVX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -208480000.00
INVX cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -27810000.00
INVX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
INVX income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -52512000.00
INVX income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 14655000.00
INVX balance_sheet (annual, 2024-12-31) — Retained Earnings: 211250000.00
INVX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 211250000.00
INVX cash_flow (annual, 2024-12-31) — Sale Of Business: 154312000.00
INVX cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
INVX cash_flow (annual, 2024-12-31) — Sale Of PPE: 3247000.00
INVX cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 1194000.00
INVX income_statement (annual, 2024-12-31) — Selling General And Administration: 116181000.00
INVX income_statement (quarterly, 2024-12-31) — Selling General And Administration: 38278000.00
INVX balance_sheet (annual, 2024-12-31) — Share Issued: 69178262.00
INVX balance_sheet (quarterly, 2024-12-31) — Share Issued: 69178262.00
INVX income_statement (annual, 2024-12-31) — Special Income Charges: 49644000.00
INVX income_statement (quarterly, 2024-12-31) — Special Income Charges: -14488000.00
INVX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 13248000.00
INVX cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 1424000.00
INVX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 958156000.00
INVX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 958156000.00
INVX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 789617000.00
INVX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 789617000.00
INVX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 843948.00
INVX income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -3042480.00
INVX income_statement (annual, 2024-12-31) — Tax Provision: 2487000.00
INVX income_statement (quarterly, 2024-12-31) — Tax Provision: -4375000.00
INVX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.02
INVX income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.21
INVX balance_sheet (annual, 2024-12-31) — Taxes Receivable: 21775000.00
INVX balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 21775000.00
INVX balance_sheet (annual, 2024-12-31) — Total Assets: 1197483000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Assets: 1197483000.00
INVX balance_sheet (annual, 2024-12-31) — Total Capitalization: 978179000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 978179000.00
INVX balance_sheet (annual, 2024-12-31) — Total Debt: 91068000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Debt: 91068000.00
INVX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 958156000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 958156000.00
INVX income_statement (annual, 2024-12-31) — Total Expenses: 575560000.00
INVX income_statement (quarterly, 2024-12-31) — Total Expenses: 216134000.00
INVX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 239327000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 239327000.00
INVX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 556092000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 556092000.00
INVX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 76669000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 76669000.00
INVX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 49075000.00
INVX income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 26912000.00
INVX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 13733000.00
INVX balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 13733000.00
INVX income_statement (annual, 2024-12-31) — Total Unusual Items: 49644000.00
INVX income_statement (quarterly, 2024-12-31) — Total Unusual Items: -14488000.00
INVX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 49644000.00
INVX income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -14488000.00
INVX balance_sheet (annual, 2024-12-31) — Work In Process: 24080000.00
INVX balance_sheet (quarterly, 2024-12-31) — Work In Process: 24080000.00
INVX balance_sheet (annual, 2024-12-31) — Working Capital: 478733000.00
INVX balance_sheet (quarterly, 2024-12-31) — Working Capital: 478733000.00
INVX income_statement (quarterly, 2025-03-31) — +Operating Expense: 47294000.00
INVX income_statement (quarterly, 2025-03-31) — +Total Revenue: 240415000.00
INVX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 76391000.00
INVX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 293652000.00
INVX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -82051000.00
INVX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 756548000.00
INVX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 2924000.00
INVX balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 5760000.00
INVX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 69290100.00
INVX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.21
INVX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 73278000.00
INVX balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 72509000.00
INVX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -7056000.00
INVX cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -7056000.00
INVX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 68136000.00
INVX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 693000.00
INVX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 68116000.00
INVX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 68116000.00
INVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -13399000.00
INVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -23466000.00
INVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 31090000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 10807000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -21860000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Inventory: 5626000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -1182000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -11657000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Payable: 10807000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -11053000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 833000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 4721000.00
INVX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -12712000.00
INVX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 4721000.00
INVX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -5775000.00
INVX balance_sheet (quarterly, 2025-03-31) — Common Stock: 693000.00
INVX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 978376000.00
INVX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -626000.00
INVX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 163911000.00
INVX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 29824000.00
INVX balance_sheet (quarterly, 2025-03-31) — Current Assets: 632638000.00
INVX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 17091000.00
INVX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 17091000.00
INVX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 11128000.00
INVX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 11128000.00
INVX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 145819000.00
INVX cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 6268000.00
INVX cash_flow (quarterly, 2025-03-31) — Deferred Tax: 6268000.00
INVX cash_flow (quarterly, 2025-03-31) — Depreciation: 17878000.00
INVX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 17878000.00
INVX income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 14945000.00
INVX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 17878000.00
INVX income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 14945000.00
INVX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 69477519.00
INVX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.21
INVX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 14757000.00
INVX income_statement (quarterly, 2025-03-31) — EBIT: 29210000.00
INVX income_statement (quarterly, 2025-03-31) — EBITDA: 47088000.00
INVX income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
INVX cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 0.00
INVX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 613000.00
INVX cash_flow (quarterly, 2025-03-31) — End Cash Position: 68116000.00
INVX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -13399000.00
INVX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 206104000.00
INVX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 24034000.00
INVX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 118000.00
INVX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -148000.00
INVX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4247000.00
INVX balance_sheet (quarterly, 2025-03-31) — Goodwill: 75568000.00
INVX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 180314000.00
INVX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 293652000.00
INVX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 327437000.00
INVX income_statement (quarterly, 2025-03-31) — Gross Profit: 76504000.00
INVX income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 2924000.00
INVX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 4954000.00
INVX balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 0.00
INVX income_statement (quarterly, 2025-03-31) — Interest Expense: 700000.00
INVX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 700000.00
INVX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 617000.00
INVX balance_sheet (quarterly, 2025-03-31) — Interest Payable: 55000.00
INVX balance_sheet (quarterly, 2025-03-31) — Inventory: 269251000.00
INVX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 992972000.00
INVX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -23466000.00
INVX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 80450000.00
INVX balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 25709000.00
INVX balance_sheet (quarterly, 2025-03-31) — Leases: 59030000.00
INVX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 51045000.00
INVX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 14596000.00
INVX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 65641000.00
INVX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 80450000.00
INVX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -91909000.00
INVX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 91919000.00
INVX cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -17413000.00
INVX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -626000.00
INVX income_statement (quarterly, 2025-03-31) — Net Income: 14757000.00
INVX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 14757000.00
INVX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 14757000.00
INVX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 14757000.00
INVX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 14757000.00
INVX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 14757000.00
INVX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 14757000.00
INVX income_statement (quarterly, 2025-03-31) — Net Interest Income: -700000.00
INVX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -11459000.00
INVX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -11459000.00
INVX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -700000.00
INVX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1314000.00
INVX balance_sheet (quarterly, 2025-03-31) — Net PPE: 245386000.00
INVX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 1003000.00
INVX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 798062000.00
INVX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 128992000.00
INVX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 726000.00
INVX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 128992000.00
INVX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 726000.00
INVX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 54448000.00
INVX income_statement (quarterly, 2025-03-31) — Normalized Income: 19840856.96
INVX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 31090000.00
INVX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 118000.00
INVX income_statement (quarterly, 2025-03-31) — Operating Income: 29210000.00
INVX income_statement (quarterly, 2025-03-31) — Operating Revenue: 240415000.00
INVX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 69337922.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3156000.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 4093000.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -4247000.00
INVX income_statement (quarterly, 2025-03-31) — Other Income Expense: -7146000.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 104746000.00
INVX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 91000.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 8673000.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 5441000.00
INVX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 214000.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Properties: 78270000.00
INVX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 5512000.00
INVX balance_sheet (quarterly, 2025-03-31) — Payables: 83683000.00
INVX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 113507000.00
INVX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
INVX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 17261000.00
INVX income_statement (quarterly, 2025-03-31) — Pretax Income: 21364000.00
INVX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INVX cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 0.00
INVX cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -17413000.00
INVX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 35101000.00
INVX balance_sheet (quarterly, 2025-03-31) — Receivables: 269094000.00
INVX balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -57632000.00
INVX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 160978000.00
INVX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 17878000.00
INVX income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 12396000.00
INVX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -91909000.00
INVX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -626000.00
INVX income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 4288000.00
INVX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 225382000.00
INVX cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 1003000.00
INVX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 32349000.00
INVX balance_sheet (quarterly, 2025-03-31) — Share Issued: 69337922.00
INVX income_statement (quarterly, 2025-03-31) — Special Income Charges: -7360000.00
INVX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1766000.00
INVX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 978376000.00
INVX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 798062000.00
INVX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -2276143.04
INVX income_statement (quarterly, 2025-03-31) — Tax Provision: 6607000.00
INVX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.31
INVX balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 27562000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Assets: 1196003000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 992972000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Debt: 82732000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 978376000.00
INVX income_statement (quarterly, 2025-03-31) — Total Expenses: 211205000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 217627000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 563365000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 71808000.00
INVX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 21850000.00
INVX income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 700000.00
INVX balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 7292000.00
INVX income_statement (quarterly, 2025-03-31) — Total Unusual Items: -7360000.00
INVX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -7360000.00
INVX balance_sheet (quarterly, 2025-03-31) — Work In Process: 28046000.00
INVX balance_sheet (quarterly, 2025-03-31) — Working Capital: 486819000.00
INVX income_statement (quarterly, 2025-06-30) — +Operating Expense: 43809000.00
INVX income_statement (quarterly, 2025-06-30) — +Total Revenue: 224234000.00
INVX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 65321000.00
INVX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 243273000.00
INVX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -87740000.00
INVX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 760306000.00
INVX cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 503000.00
INVX balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 42883000.00
INVX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 68943387.00
INVX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.22
INVX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 68116000.00
INVX balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 46681000.00
INVX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7297000.00
INVX cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -7297000.00
INVX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 71051000.00
INVX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 688000.00
INVX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 68781000.00
INVX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 68781000.00
INVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2442000.00
INVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -62872000.00
INVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 59210000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -17996000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 9562000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 8838000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 70000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 17526000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Payable: -17996000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -8434000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -6628000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 3118000.00
INVX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 14490000.00
INVX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 3118000.00
INVX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1220000.00
INVX balance_sheet (quarterly, 2025-06-30) — Common Stock: 688000.00
INVX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 995553000.00
INVX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -8654000.00
INVX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 152515000.00
INVX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 40021000.00
INVX balance_sheet (quarterly, 2025-06-30) — Current Assets: 670105000.00
INVX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 18279000.00
INVX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 18279000.00
INVX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 6911000.00
INVX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 6911000.00
INVX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 145745000.00
INVX cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 7625000.00
INVX cash_flow (quarterly, 2025-06-30) — Deferred Tax: 7625000.00
INVX cash_flow (quarterly, 2025-06-30) — Depreciation: 18013000.00
INVX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 18013000.00
INVX income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 14974000.00
INVX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 18013000.00
INVX income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 14974000.00
INVX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 69147457.00
INVX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.22
INVX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 15345000.00
INVX income_statement (quarterly, 2025-06-30) — EBIT: 22787000.00
INVX income_statement (quarterly, 2025-06-30) — EBITDA: 40800000.00
INVX income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 0.00
INVX cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 0.00
INVX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1885000.00
INVX cash_flow (quarterly, 2025-06-30) — End Cash Position: 68781000.00
INVX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2442000.00
INVX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 218940000.00
INVX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 51913000.00
INVX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -605000.00
INVX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 419000.00
INVX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2481000.00
INVX balance_sheet (quarterly, 2025-06-30) — Goodwill: 94136000.00
INVX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 218864000.00
INVX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 243273000.00
INVX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 294922000.00
INVX income_statement (quarterly, 2025-06-30) — Gross Profit: 71719000.00
INVX income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 503000.00
INVX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 3162000.00
INVX balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
INVX income_statement (quarterly, 2025-06-30) — Interest Expense: 551000.00
INVX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 551000.00
INVX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 103000.00
INVX balance_sheet (quarterly, 2025-06-30) — Interest Payable: 223000.00
INVX balance_sheet (quarterly, 2025-06-30) — Inventory: 278495000.00
INVX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1023195000.00
INVX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -62872000.00
INVX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 55750000.00
INVX balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 13495000.00
INVX balance_sheet (quarterly, 2025-06-30) — Leases: 61685000.00
INVX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 52772000.00
INVX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 27642000.00
INVX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 80414000.00
INVX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 55750000.00
INVX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -44219000.00
INVX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 92309000.00
INVX cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -63256000.00
INVX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -8654000.00
INVX income_statement (quarterly, 2025-06-30) — Net Income: 15345000.00
INVX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 15345000.00
INVX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 15345000.00
INVX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 15345000.00
INVX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 15345000.00
INVX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 15345000.00
INVX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 15345000.00
INVX income_statement (quarterly, 2025-06-30) — Net Interest Income: -551000.00
INVX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 11531000.00
INVX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 11531000.00
INVX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -551000.00
INVX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -435000.00
INVX balance_sheet (quarterly, 2025-06-30) — Net PPE: 207182000.00
INVX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 7681000.00
INVX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 776689000.00
INVX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 122129000.00
INVX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1410000.00
INVX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 122129000.00
INVX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1410000.00
INVX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 46015000.00
INVX income_statement (quarterly, 2025-06-30) — Normalized Income: 18943350.00
INVX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 59210000.00
INVX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -605000.00
INVX income_statement (quarterly, 2025-06-30) — Operating Income: 27910000.00
INVX income_statement (quarterly, 2025-06-30) — Operating Revenue: 224234000.00
INVX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 68779153.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 5228000.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 6678000.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2481000.00
INVX income_statement (quarterly, 2025-06-30) — Other Income Expense: -5123000.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 124728000.00
INVX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 80000.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 8801000.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 3959000.00
INVX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 92000.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Properties: 80752000.00
INVX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 3124000.00
INVX balance_sheet (quarterly, 2025-06-30) — Payables: 73856000.00
INVX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 113877000.00
INVX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
INVX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 17890000.00
INVX income_statement (quarterly, 2025-06-30) — Pretax Income: 22236000.00
INVX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
INVX cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -63256000.00
INVX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 39720000.00
INVX balance_sheet (quarterly, 2025-06-30) — Receivables: 256828000.00
INVX balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -22307000.00
INVX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 149476000.00
INVX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 18013000.00
INVX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -44219000.00
INVX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -8654000.00
INVX income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 5131000.00
INVX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 232078000.00
INVX cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 7681000.00
INVX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 28835000.00
INVX balance_sheet (quarterly, 2025-06-30) — Share Issued: 68779153.00
INVX income_statement (quarterly, 2025-06-30) — Special Income Charges: -5215000.00
INVX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3759000.00
INVX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 995553000.00
INVX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 776689000.00
INVX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -1616650.00
INVX income_statement (quarterly, 2025-06-30) — Tax Provision: 6891000.00
INVX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.31
INVX balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 32738000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Assets: 1227081000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1023195000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Debt: 98693000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 995553000.00
INVX income_statement (quarterly, 2025-06-30) — Total Expenses: 196324000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 231528000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 556976000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 85783000.00
INVX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 22695000.00
INVX balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 8535000.00
INVX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -5215000.00
INVX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -5215000.00
INVX balance_sheet (quarterly, 2025-06-30) — Work In Process: 19835000.00
INVX balance_sheet (quarterly, 2025-06-30) — Working Capital: 524360000.00
INVX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 240633000.00
INVX balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -20225000.00
INVX income_statement (annual, 2025-12-31) — +Operating Expense: 189535000.00
INVX income_statement (quarterly, 2025-12-31) — +Operating Expense: 47496000.00
INVX income_statement (annual, 2025-12-31) — +Total Revenue: 978251000.00
INVX income_statement (quarterly, 2025-12-31) — +Total Revenue: 273602000.00
INVX balance_sheet (annual, 2025-12-31) — Accounts Payable: 60711000.00
INVX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 60711000.00
INVX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 229674000.00
INVX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 229674000.00
INVX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -102372000.00
INVX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -102372000.00
INVX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 767650000.00
INVX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 767650000.00
INVX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3427000.00
INVX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
INVX balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
INVX balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
INVX income_statement (annual, 2025-12-31) — Basic Average Shares: 69009209.00
INVX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 68994818.00
INVX income_statement (annual, 2025-12-31) — Basic EPS: 1.21
INVX income_statement (quarterly, 2025-12-31) — Basic EPS: 0.20
INVX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 73278000.00
INVX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 163374000.00
INVX balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 50168000.00
INVX balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 50168000.00
INVX cash_flow (annual, 2025-12-31) — Capital Expenditure: -35132000.00
INVX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -8927000.00
INVX cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -35132000.00
INVX cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -8927000.00
INVX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 79287000.00
INVX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 79287000.00
INVX balance_sheet (annual, 2025-12-31) — Capital Stock: 691000.00
INVX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 691000.00
INVX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 203407000.00
INVX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 203407000.00
INVX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 203407000.00
INVX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 203407000.00
INVX cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
INVX cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
INVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -44919000.00
INVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2785000.00
INVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -18741000.00
INVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -9958000.00
INVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 190912000.00
INVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 52238000.00
INVX cash_flow (annual, 2025-12-31) — Change In Account Payable: -12698000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -5112000.00
INVX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -19075000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 860000.00
INVX cash_flow (annual, 2025-12-31) — Change In Inventory: 46625000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Inventory: 26162000.00
INVX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -3837000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -2101000.00
INVX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -20224000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -31191000.00
INVX cash_flow (annual, 2025-12-31) — Change In Payable: -12698000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Payable: -5112000.00
INVX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -31773000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -4252000.00
INVX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 10859000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 8169000.00
INVX cash_flow (annual, 2025-12-31) — Change In Receivables: 17631000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Receivables: 13418000.00
INVX cash_flow (annual, 2025-12-31) — Change In Working Capital: 19281000.00
INVX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 10205000.00
INVX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 17631000.00
INVX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 13418000.00
INVX cash_flow (annual, 2025-12-31) — Changes In Cash: 127252000.00
INVX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 39495000.00
INVX balance_sheet (annual, 2025-12-31) — Common Stock: 691000.00
INVX balance_sheet (quarterly, 2025-12-31) — Common Stock: 691000.00
INVX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1057699000.00
INVX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1057699000.00
INVX cash_flow (annual, 2025-12-31) — Common Stock Payments: -9280000.00
INVX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
INVX income_statement (annual, 2025-12-31) — Cost Of Revenue: 674971000.00
INVX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 194488000.00
INVX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 39163000.00
INVX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 39163000.00
INVX balance_sheet (annual, 2025-12-31) — Current Assets: 728047000.00
INVX balance_sheet (quarterly, 2025-12-31) — Current Assets: 728047000.00
INVX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 19379000.00
INVX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 19379000.00
INVX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 19379000.00
INVX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 19379000.00
INVX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 11986000.00
INVX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 11986000.00
INVX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 11986000.00
INVX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 11986000.00
INVX balance_sheet (annual, 2025-12-31) — Current Liabilities: 148164000.00
INVX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 148164000.00
INVX cash_flow (annual, 2025-12-31) — Deferred Income Tax: 34291000.00
INVX cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2974000.00
INVX cash_flow (annual, 2025-12-31) — Deferred Tax: 34291000.00
INVX cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2974000.00
INVX cash_flow (annual, 2025-12-31) — Depreciation: 73240000.00
INVX cash_flow (quarterly, 2025-12-31) — Depreciation: 18734000.00
INVX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 73240000.00
INVX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 18734000.00
INVX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 60742000.00
INVX income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 15461000.00
INVX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 73240000.00
INVX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 18734000.00
INVX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 60742000.00
INVX income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 15461000.00
INVX income_statement (annual, 2025-12-31) — Diluted Average Shares: 69381412.00
INVX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 69641691.00
INVX income_statement (annual, 2025-12-31) — Diluted EPS: 1.20
INVX income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.20
INVX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 83298000.00
INVX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 13968000.00
INVX income_statement (annual, 2025-12-31) — EBIT: 131111000.00
INVX income_statement (quarterly, 2025-12-31) — EBIT: 27621000.00
INVX income_statement (annual, 2025-12-31) — EBITDA: 204351000.00
INVX income_statement (quarterly, 2025-12-31) — EBITDA: 46355000.00
INVX income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 0.00
INVX income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 0.00
INVX cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
INVX cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
INVX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2877000.00
INVX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 538000.00
INVX cash_flow (annual, 2025-12-31) — End Cash Position: 203407000.00
INVX cash_flow (quarterly, 2025-12-31) — End Cash Position: 203407000.00
INVX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -44919000.00
INVX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2785000.00
INVX balance_sheet (annual, 2025-12-31) — Finished Goods: 204957000.00
INVX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 204957000.00
INVX cash_flow (annual, 2025-12-31) — Free Cash Flow: 155780000.00
INVX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 43311000.00
INVX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -40082000.00
INVX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 1255000.00
INVX income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 39825000.00
INVX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -1364000.00
INVX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4084000.00
INVX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4084000.00
INVX balance_sheet (annual, 2025-12-31) — Goodwill: 99720000.00
INVX balance_sheet (quarterly, 2025-12-31) — Goodwill: 99720000.00
INVX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 215950000.00
INVX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 215950000.00